Clinical Trial Update: Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy Volunteers [Phase 1]

View source ↗

Summary

AstraZeneca conducted a Phase 1 study to characterize the uptake, breakdown, and elimination of an unnamed investigational drug in healthy volunteers; the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Unnamed investigational drug

Snippet

Sponsor: AstraZeneca | Conditions: Alzheimer's Disease | Phase 1 | Status: TERMINATED